Thank you for your interest in clinical trials for Polycythemia VeraPlease click "Search" to find Polycythemia Vera clinical trials and medical research studies.If you receive too many study listings you may enter your zip code to find the locations closest to you.
Your search returned 3 studies. (Get alerts for new studies):Myelofibrosis - Winter Park FLPolycythemia Vera - Winter Park FLMyelofibrosis - Winter Park FL
Your search returned 17 studies. (Get alerts for new studies):Research Tissue BankConditions: Myelofibrosis - Idiopathic Myelofibrosis - Essential Thrombocythemia - Polycythemia Vera9 Locations availablePolycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET GenesConditions: Polycythemia Vera - Essential Thrombocythemia - Myelofibrosis1 Location availablePegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)Conditions: High Risk Polycythemia Vera - High Risk Essential Thrombocythemia5 Locations availablePomalidomide for Myelofibrosis PatientsConditions: Polycythemia Vera - Thrombocythemia1 Location availableRandomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)Conditions: High Risk Polycythemia Vera - High Risk Essential Thrombocythemia2 Locations availableCorrelative Biomarker Study in Patients With Myeloproliferative DisordersConditions: Myeloproliferative Disease - Myelofibrosis - Idiopathic Myelofibrosis - Essential Thrombocythemia - Polycythemia Vera6 Locations availableAlternative Dosing Strategy of Ruxolitinib in Patients With MyelofibrosisConditions: Primary Myelofibrosis - Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase15 Locations availableStudy With SAR302503 in Patients With Polycythemia Vera or Essential ThrombocythemiaConditions: Hematopoietic Neoplasm3 Locations availableSafety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia Conditions: Primary Myelofibrosis - Post-Polycythemic Vera Myelofibrosis - Post-Essential Thrombocythemia Myelofibrosis2 Locations availableCEP-701 (Lestaurtinib) in MyelofibrosisConditions: Myelofibrosis - Essential Thrombocythemia - Polycythemia Vera7 Locations availableA Study in Myeloproliferative DisordersConditions: Myeloproliferative Disorders - Thrombocythemia, Essential - Polycythemia Vera - Primary Myelofibrosis3 Locations availableStudy of the JAK Inhibitor Ruxolitinib Administered Orally to Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF)Conditions: Myelofibrosis3 Locations availableSafety Study Evaluating Twice-Daily Administration of CYT387 in Primary Myelofibrosis or Post-Polycythemia Vera or Post-Essential Thrombocythemia MyelConditions: Primary Myelofibrosis - Post-Polycythemia Vera - Post-Essential Thrombocythemia Myelofibrosis3 Locations availableFamilial Myeloproliferative DisordersConditions: Polycythemia Vera - Essential Thrombocythemia - Idiopathic Myelofibrosis5 Locations availableTrial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia VeraConditions: Polycythemia Vera1 Location availableStudy of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) TabletConditions: Polycythemia Vera51 Locations availableRuxolitinib (INCB018424) in Subjects With Primary Myelofibrosis, Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosisConditions: Primary Myelofibrosis - Post Essential Thrombocythemia-myelofibrosis - Post Polycythemia Vera-myelofibrosis34 Locations available
Didn't find what you were looking for? Try these alternatives: